posted on Jun, 10 2004 @ 05:06 AM
Scientists have identified a gene which could identify how aggressive a man's prostate cancer will be.
The research, by experts at the Institute of Cancer Research Everyman Centre, should lead to a test to identify aggressive cancers.
The E2F3 gene may also act as a focus for the development of drugs to treat prostate cancer, the most common to affect UK men, the researchers say.
The findings will be published in the journal Oncogene.
Twenty-seven thousand prostate cases are diagnosed each year and the disease kills 10,000 men a year.
Breast cancer drug is lifesaver
A breast cancer drug could save the lives of thousands of women living with the disease.
Research on women with early stage breast cancer found taking letrozole after a course of another drug, tamoxifen, cut death rates by 39%
Until now there have been no treatment options for women who finish their course of tamoxifen after five years.
The international study, of 5,200 women, included five hospitals in the UK.
A-Z of cancer
Welsh Cancer Bank 'first for UK'